Live Chat ×
Skip to main content

Nasally Administered Drug Products: Clinically Relevant In-vitro Tests

Thank you

This live web event has ended. Thank you for attending.

Contributors

  • Mandana Azimi (GSK Consumer Healthcare )

    Mandana Azimi is an innovation scientist working at GlaxoSmithKline consumer healthcare in the respiratory division. She received her doctorate degree in Pharmacy from Tabriz University of Medical Sciences in Iran in 2006 and Ph.D. in Pharmaceutical Sciences from Virginia Commonwealth University (VCU) in 2017. She started her career at Jalinus Pharmaceutical Co. as a scientist and was promoted to Research and Development Manager shortly after.
    Before beginning her Ph.D., she gained extensive skills in respiratory drug delivery with Dr. Michael Hindle at VCU, which led to 4 publications. Throughout her Ph.D., she authored a publication which was presented at the Respiratory Drug Delivery Europe conference in 2015 and had two podium presentations at Drug Delivery to the Lungs in 2016 and International Society of Aerosol Medicine, 2017.

    Her Ph.D. research was focused on developing new in vitro realistic test methods for nasal spray devices and identifying the key parameters influencing their regional nasal deposition. Also, she worked on the design and delivery of a dry powder antibiotic nanocomposite for enhanced targeted delivery to the middle passages in the nasal cavity and paranasal sinuses with minimal delivery to the lungs.

May 24, 2018
Thu 12:30 PM EDT

Duration 1H 30M

This live web event has ended.